Otezla (apremilast) is a prescription drug that’s used to treat plaque psoriasis, psoriatic arthritis, and mouth sores related to Behçet’s disease in certain people. Otezla comes as an oral ...

Otezla (apremilast) can cause side effects that range from mild to serious. More common side effects include headache, upper respiratory infection, and nausea. If side effects from Otezla become ...

Otezla ® (apremilast) is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP).

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis.Common ...

Otezla (apremilast) and cost Medically reviewed by Heather Bruce, PharmD — Written by Jennifer Mitri Williamson, Pharm.D. — Updated on February 7, 2024 Coupons and savings ...

OTEZLA ® (apremilast) is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP).

Results from the POETYK PSO-1 and POETYK PSO-2 showed that 58% and 53% respectively of patients treated with Sotyktu achieved 75% skin clearance, versus 35% and 40% for Otezla.

Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for the ...

THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food ...

Amgen has announced the availability of Otezla (apremilast) in the US for paediatric patients with moderate to severe plaque psoriasis, [a skin lesion condition]. It is the first and only pill for ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.